Shoulder Innovations grants 88,450 stock options

Shoulder Innovations, Inc. reported that officer David Lawrence Blue received a grant of stock options on January 30, 2026.

Accepted by SEC EDGAR 02/03/2026 - 04:39 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Shoulder Innovations, Inc. reported that officer David Lawrence Blue received a grant of stock options on January 30, 2026. The award covers 88,450 options for common stock at an exercise price of $14.16 per share, all held as a direct ownership position.

The options vest in four equal annual installments. One-fourth of the underlying shares will vest on March 1 each year, beginning March 1, 2027, until fully vested. After this grant, Blue beneficially owns 88,450 derivative securities in the form of these stock options.

Insider Trade Summary

Grant/Award: 88,450 shares

Grant/Award 1 txn

Insider Blue David Lawrence

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	88,450	$0.00	$0.00

Holdings After Transaction: Stock Option — 88,450 contracts (Direct)

Holdings Before and After: Stock Option, 0 to 88,450 contracts (Direct)

Footnotes (1)

1. F1. The stock option vests as to one-fourth of the underlying shares on March 1st each year, beginning on March 1, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the insider involved in this Shoulder Innovations (SI) Form 4 filing?

The filing reports a transaction by officer David Lawrence Blue of Shoulder Innovations, Inc. He is listed as an officer of the company, with additional details about his specific role referenced in the remarks section of the filing.

What type of securities did David Lawrence Blue receive from Shoulder Innovations (SI)?

David Lawrence Blue received a grant of stock options linked to Shoulder Innovations common stock. The grant covers 88,450 derivative securities, each representing the right to purchase one share of the company’s common stock at a fixed exercise price.

How many stock options were granted in this Shoulder Innovations (SI) Form 4?

The Form 4 shows a grant of 88,450 stock options to officer David Lawrence Blue. These options give him the right to buy up to 88,450 shares of Shoulder Innovations common stock if and when they vest and are exercised.

What is the exercise price of the stock options granted by Shoulder Innovations (SI)?

The stock options granted to David Lawrence Blue carry an exercise price of $14.16 per share. This means he can acquire Shoulder Innovations common stock at $14.16 for each option, once the options have vested and subject to any applicable terms.

What is the vesting schedule for David Lawrence Blue’s Shoulder Innovations (SI) stock options?

The stock options vest over four years, with one-fourth of the shares vesting on March 1 each year. Vesting begins on March 1, 2027, and continues annually until the entire 88,450-option grant is fully vested.

How many derivative securities does David Lawrence Blue own after this Shoulder Innovations (SI) transaction?

After this transaction, David Lawrence Blue beneficially owns 88,450 derivative securities in the form of stock options. All of these options are reported as being held directly, according to the ownership information in the Form 4.

When do the Shoulder Innovations (SI) stock options granted to David Lawrence Blue expire?

The granted stock options have an expiration date of January 30, 2033. If they are not exercised by that date, the options will lapse, and the right to purchase the underlying Shoulder Innovations common shares will be forfeited.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blue David Lawrence

(Last) (First) (Middle)

C/O SHOULDER INNOVATIONS, INC.

1535 STEELE AVENUE SW, SUITE B

(Street)

GRAND RAPIDS MI 49507

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SHOULDER INNOVATIONS, INC. [ SI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$14.16	01/30/2026		A		88,450		(1)	01/30/2033	Common Stock	88,450	$0	88,450	D

Explanation of Responses:

1. The stock option vests as to one-fourth of the underlying shares on March 1st each year, beginning on March 1, 2027.

Remarks:

	/s/ Jeffrey Points, as Attorney-in-Fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.